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Introduction: Circulating plasma proteins play an important role in various diseases, and 
analysis of the plasma proteome has led to the discovery of various disease biomarkers. 
Osteoarthritis (OA) is the most common chronic joint disease, mostly affecting people of 
older age. OA typically starts as a focal disease (in a single compartment, typically treated 
with unicompartmental knee replacement), and then progresses to the other compartments (if 
not treated in time, typically treated with total knee replacement). For this, identification of 
differential proteins was carried out in plasma samples of OA cases and compared with 
healthy controls. The aim of this study was to identify circulatory differentially expressed 
proteins (DEPs) in knee-OA patients undergoing total knee replacement or unicompartmental 
knee replacement compared to healthy controls and assess their role, in order to have better 
understanding of the etiology behind OA pathophysiology.
Methods: DEPs were identified with two-dimensional gel electrophoresis (2DE) and iso-
baric tags for relative and absolute quantification (iTRAQ), followed by liquid chromato-
graphy with tandem mass spectrometry. Validation of DEPs was carried out using Western 
blot and ELISA. Posttranslational modifications were checked after running native gel using 
purified protein from patients, followed by detection of autoantibodies.
Results: In total, 52 DEPs were identified, among which 45 were distinct DEPs. 
Haptoglobin (Hp) was identified as one of the most significantly upregulated proteins in 
OA (P=0.005) identified by both 2DE and iTRAQ. Decreased levels of Hp tetramers and 
increased levels of autoantibodies against Hpβ were observed in OA plasma.
Conclusion: Our data suggest that poor clearance of free hemoglobin and low levels of Hp 
tetramers may be associated with OA pathogenesis and inflammation.
Keywords: osteoarthritis, blood, haptoglobin, hemoglobin, biomarker, inflammation
Introduction
Osteoarthritis (OA) is the most common chronic joint disease associated with 
aging.1 Currently, OA accounts for 25% of joint problems2 and is the major 
cause of disability, leading to poor quality of life in the adult population. The 
etiology of OA is not yet well understood. OA pathogenesis is multifactorial, and 
its contributing factors are broadly linked to genetics, diet, lifestyle, injury, and 
obesity.3,4
There is currently a lack of knowledge regarding the cellular and molecular 
mechanisms initiating the disease and factors leading to bone and cartilage degra-
dation and progression.5 Due to this lack of knowledge, OA treatment is largely 
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symptomatic (ie, controlling pain or modifying lifestyle), 
allowing the disease to progress. Uncontrolled progression 
of OA ultimately leads to the need for a joint replacement, 
which is associated with considerable socioeconomic bur-
den and medical complications.6 Currently, various ima-
ging techniques, such as X-rays and magnetic resonance 
imaging, are used for diagnosis and grading of severity of 
OA, but these can only detect cartilage and bone degrada-
tion once they have already taken place.7
For joint replacement, OA patients are recommended either 
unicompartmental knee replacement (UKR) or total KR 
(TKR) surgery. In UKR, both cruciate ligaments and the two 
knee compartments are preserved, leading to faster recovery, 
more normal gait, better knee flexion, and lower cost than 
TKR.8,9 Normally, TKR is preferred, because of perception 
that it is more durable,10–12 despite the fact that up to 50% 
patients requiring KRs are suitable for a UKR.13–15 It would be 
useful to identify any specific biomarkers that are more com-
monly found in patients needing a UKR or those needing 
a TKR. There is significant interest and an absolute need to 
identify biomarkers, in order to understand the etiology behind 
OA pathogenesis and inform early clinical diagnosis, prog-
nosis, and surgical choices for OA. Recently, strategies for 
biomarker discovery have included genomics, proteomics, 
metabolomics, and transcriptomics to identify candidate 
markers.16,17
The aim of the present study was to identify differentially 
expressed proteins (DEPs) between UKR and TKR OA cases 
and healthy controls (HCs). For this, we applied proteomic 
techniques (isobaric tags for relative and absolute quantifica-
tion [iTRAQ] and two-dimensional gel electrophoresis 
[2DE]) followed by liquid chromatography with tandem 
mass-spectrometry (LC-MS/MS) using blood as a source 
sample. Blood is widely used for screening of potential pro-
tein biomarkers, because it is easy to access and offers the 
possibility of using large cohorts and repeated sampling.18,19
Proteomics has emerged as a highly promising technique 
for rapid detection of differentially expressed proteome pro-
files and biomarker discovery in biological samples. This 
method is widely used for the discovery of disease- 
associated biomarkers and understanding the pathogenesis 
of a number of diseases,20 where the most common method 
applied is a combination of 2DE and mass spectrometry.21 
However significant improvements can be made by applying 
more advanced technique — iTRAQ.22
In this study, we identified 52 DEPs in OA patients’ plasma 
using both 2DE and iTRAQ. Haptoglobin (Hp), a free hemo-
globin–scavenging protein,23 was identified as the most 
significant DEP, validated by Western blot and ELISA. 
Further, pure protein was purified by Immunoprecipitation 
(IP) and checked for posttranslational modifications (PTMs). 
Free hemoglobin detection in OA plasma was also carried out 
to validate our findings and demonstrate its utility and potential 
specificity for clinical diagnosis.
Methods
Patients
All OA patients (TKR and UKR, n=58) recruited fulfilled 
the American College of Rheumatology criteria for diag-
nosis of knee OA,24 with detailed disease history. All 
patients included in this study had a Kellgren–Lawrence 
(KL) score of 4 and had been referred to undergo either 
TKR or UKR. The KL grading system is a common 
method of classifying25 the severity of knee OA (using 
grades of 0–4, 4 being most severe).
Sample Collection and Processing
Whole-blood samples (4 mL) were collected from OA patients 
(TKR 45, UKR 13) in EDTA-coated vacutainers (Ptech, India) 
prior to surgery. Similarly, blood samples from HCs (n=40) 
with no clinical history of any joint-related disease, joint pain, 
or join discomfort were collected and included.25 Plasma 
samples were separated by centrifugation at 1,300 g for 10 
minutes at 4°C and stored in multiple 20 µL aliquots in an 
Eppendorf tube at −80°C deep freezer until use. Demographic 
and clinical information about the OA patients and HCs is 
presented in Supplementary Table 1.
iTRAQ Labeling and Protein Identification
Three sets of pooled plasma samples were prepared from 
each group (TKR, UKR, and HCs, each n=12) and processed 
for protein digestion by trypsin (Promega, USA) followed by 
iTRAQ labeling using different isobaric tags (TKR tag115, 
UKR tag116, HCs tag117) and incubated for 2 hours at room 
temperature. Labeled peptides were then pooled, lyophilized, 
and analyzed with iTRAQ using standard protocols. For 
quantitative analysis, proteins with two or more unique pep-
tides in at least one experiment with an unused score ≥2 only 
were considered26 (see details in Supplementary material).
Two-Dimensional Gel Electrophoresis
Plasma samples were also pooled and proteins (80µg) 
were subjected to 2DE:27,28 the first dimension with iso-
electric focusing and the second with SDS-PAGE. Gels 
were then silver-stained using standard protocols.28,29 
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Experiments were repeated at least thrice using different 
pooled samples. Based on densitometry values, protein 
spots with fold change ≥2 in TKR/UKR compared to 
HCs were screened for protein identification (see details 
in Supplementary material).
In-Gel Digestion of Proteins and 
Preparation of LC MS/MS Analysis
Protein spots were excised from 2DE gels (minimum three 
gels), processed, and run on the LC MS/MS platform 
(Applied Biosystems, USA). MS/MS spectra were pro-
cured in reflector-positive mode over a mass scope of 
10–20 kDa, and proteins having more than two unique 
peptides were considered4 (see details in Supplementary 
material).
Relationship with Major Pathways
DEPs were analyzed using DAVID (Database for 
Annotation, Visualization, and Integrated Discovery; ver-
sion 6.8), an online tool for alignment of DEPs, with major 
pathways described. It provides functional interpretation 
of large numbers of genes/proteins derived from experi-
mental studies.30 Proteins identified were first converted to 
their NCBI gene ID, then searched for associated 
pathways with maximum DEP hits.
Western Blot
Pooled plasma protein (20µg) from each group (TKR, 
UKR and HC) was separated by 12% SDS-PAGE and 
Western blot performed with an anti-Hp antibody 
(1:3,000), using standard procedures31 (see details in 
Supplementary material). Densitometry values of Western 
blot analysis were normalized with total protein, as well as 
a housekeeping protein (actin) as loading control.32,33 
Experiments were repeated at least thrice.
Enzyme-Linked Immunosorbent Assays
ELISAs were performed using a commercial ELISA kit 
(CloudClone, USA) as per the manufacturer’s guideline 
using TKR (n=40), UKR (n=11), and HCs (n=17). We also 
performed indirect ELISAs manually, wherein plates were 
coated with diluted plasma samples (dilution 1:200) from 
individuals of each group (TKR 45, UKR 13, HCs 40) 
using standard protocols (see details in Supplementary 
material). The anti-Hp antibody (1:2,000) was used to 
detect Hp.27
Immunoprecipitation and Glycoprotein 
Staining
IP was performed to isolate pure Hp protein from OA and 
healthy plasma samples for detection of alteration in its 
native form using IP columns (Catch and Release version 
2.0, Millipore, USA) and the anti-Hp antibody (2 μg). 
Concentration of protein in the plasma was measured by 
the Bradford method. From each group,500 μg total pro-
tein was added to the IP column as per the manufacturer’s 
guidelines. Immunoprecipitated protein samples (20 μL) 
from each group (TKR, UKR and HC) were then run on 
native (nondenaturing conditions) gel and transferred onto 
nitrocellulose (NC) membranes. The membranes were 
then subjected to glycoprotein detection using a GelCode 
glycoprotein-staining kit (Thermo Fisher Scientific, USA). 
Protein bands thus obtained were scanned using 
a ChemiDoc MP imaging system (Bio-Rad, USA).34 The 
IP-eluted samples (20 μL) were also run on SDS-PAGE, 
followed by silver staining. All experiments were repeated 
for at least thrice (see details in Supplementary material).
ProQ Diamond Staining
Phosphoprotein staining was performed for phosphopro-
tein detection using a ProQ gel-staining kit (Invitrogen, 
USA). Native gel was run as mentioned earlier, followed 
by phosphoprotein staining of gels and scanning using the 
ChemiDoc (see details in Supplementary material)
Autoantibody Detection
Proteins (2 μg) from immunoprecipitated samples of each 
group (TKR, UKR, and HCs) and controls (IgG control 
and plasma control) were separated by 12% SDS-PAGE, 
transferred to NC membranes, and incubated with diluted 
plasma (1:500 in PBS) as a source of primary autoantibo-
dies, and incubated for 3 hours at room temperature fol-
lowed by washing, incubation with goat antihuman 
horseradish peroxidase (HRP)–conjugated secondary anti-
body (1∶5,000, Jackson, USA) for 1 hour and developed 
with an enhanced chemiluminescence agent 
(G Bioscience, USA). Densitometry analysis was carried 
out using Image Lab 3.00 (Bio-Rad). Experiments were 
repeated at least thrice (as described in Supplementary 
material).
Ubiquitination
Proteins (10 μg) from immunoprecipitated samples of each 
group (TKR, UKR, and HCs) were separated with 12% 
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SDS-PAGE, subsequently transferred to NC membranes, 
and blocked with 5% BSA. Blots were then incubated with 
antiubiquitin antibody followed by incubation with HRP- 
conjugated secondary antibody after washing. The mem-
branes were then developed as mentioned earlier (see 
details in Supplementary material).
Free-Hemoglobin Detection
Free hemoglobin detection was carried out in plasma sam-
ples using a human free-hemoglobin ELISA kit (G 
Bioscience) as per the manufacturer’s guidelines (details 
in Supplementary material).
Statistical Analysis
Data were normalized using suitable controls according to 
the platform used. Graph was plotted using optical density 
and densitometry values using Microsoft Excel and 
GraphPad Prism (version 5). To compare data from differ-
ent groups, we used nonparametric tests, as data were not 
normally distributed. Mann–Whitney U testsand ANOVA 
were used to compare data from two or more groups and 
?2 for categorical data. P<.05 was considered significant, 
and Bonferroni correction for multiple testing was applied.
Results
Identification and Quantification of 
Differentially Expressed Proteins in 
OA-Patient Plasma
In total 52 DEPs were identified using proteomic techni-
ques (2DE and iTRAQ,Table 1): 15 with 2DE (Figure 1) 
and 37 with iTRAQ (Table 1). However, with the 2DE 
method, several spots with the same accession number 
were identified per protein (probably reflecting isoforms), 
resulting in eight distinct DEPs. With iTRAQ, all 37 
identified DEPs were distinct proteins. Therefore, 45 
DEPs were identified in KL4-grade OA-patient plasma 
samples compared to HCs (P<0.05, Table 1). Among 
these 45 distinct DEPs, 30 were upregulated in TKR and 
23 in UKR, while 21 were found to be common to both 
TKR and UKR patients compared to HCs (Figure 2A). 
Similarly, 13 proteins were downregulated in TKR and 20 
in UKR, while ten were downregulated in both TKR and 
UKR patients compared to HCs (Figure 2B). Among these 
proteins, ten were highly upregulated or downregulated 
(samples 3–7, 29, 30, 32, and 34upregulated, sample 8 
downregulated; Table 1) with fold change ≥2 in OA- 
patient plasma compared to HCs. Among all DEPs, Hp 
and serum albumin were found to be up regulated on both 
techniques (2DE and iTRAQ, Table 1). Hp was one of the 
most significantly upregulated proteins (2.39-fold, P=0.05) 
in OA patients compared to HCs. As such, the mechanism 
of its overexpression in OA was investigated further.
DAVID Pathway Analysis of DEPs
DAVID pathway analysis of all the identified DEPs pro-
vided the maximum hits for the “complement and coagu-
lation pathway”. Seven proteins — A2M, F13A1, C3), 
FGA, SERPINA1, SERPINC1, and SERPINF2 — were 
found to be associated with this pathway (Supplementary 
Figure 1). Pathway enrichment indicated not only involve-
ment of immunoresponse and inflammation but also home-
ostasis or related problems among OA patients.35
Validation with Western Blot and ELISA
For initial confirmation and validation, OA (TKR 12, 
UKR 12) and HC (12) plasma samples were pooled 
from same-age and -sex participants. The DEP level of 
Hp was then validated in pooled samples with Western 
blotting (Figure 3A). Densitometry values were normal-
ized by total protein (Figure 3A, lower panel) and actin 
(Supplementary Figure 2) as loading control. 
Densitometry analysis followed by normalization 
revealed 1.5-fold and 1.4-fold increased Hp expression 
in TKR and UKR, respectively, compared to HCs (Figure 
3B). ELISAs on with individual plasma samples of OA 
(TKR 40, UKR 11) and HCs (17), revealed 0.8-fold 
(P=0.0003) and 0.95-fold (P=0.05) lower Hp levels in 
TKR and UKR than HCs, respectively. Moreover, there 
was 0.89-fold (P=0.05) lower expression in TKR than 
UKR. The corresponding concentration of Hp was 1,417 
ng/μL in TKR and 1,584 ng/μL in UKR compared to 
1,655 ng/μL in HC plasma samples (Figure 3C). Further, 
the results of indirect ELISAs performed manually with 
increased sample sizes also revealed similar results 
(Supplementary Figure 3). The ELISA results were thus 
observed to be contradictory to our findings on 2DE gel, 
iTRAQ, and Western blot analysis. The main difference 
between Western blot and ELISA is that Western blot 
measures denatured protein with linearized epitope anti-
bodies and is more likely to be able to quantify total 
protein. In contrast, ELISA measures native protein and 
may be sensitive to PTMs, protein complexes, and struc-
tural epitopes.
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Table 1 Differentially expressed proteins (DEPs) identified by iTRAQ and 2DE in TKR/UKR blood plasma samples compared to HCs




















181 1 Haptoglobin/ sp| 
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HPT_HUMAN
24 Serum albumin/ 
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147 2 Transthyretin/ tr| 
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209 Haptoglobin/ tr| 
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J3QR68_HUMAN
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Table 1 (Continued). 
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16 25.4 sp|P02763| 
A1AG1_HUMAN
α1-acid glycoprotein 
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Table 1 (Continued). 












































23 22.9 sp|P19652| 
A1AG2_HUMAN
α1-acid glycoprotein 
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Table 1 (Continued). 














27 9.9 tr|A0A286YEY4| 
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29 3.8 sp|P02671| 
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31 4.6 sp|P00488| 
F13A_HUMAN
Coagulation factor 
























submit your manuscript | www.dovepress.com                                                                                                                                                                                                                    
DovePress                                                                                                                                                
Journal of Inflammation Research 2021:14 956




































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Posttranslational Modification and Level 
of Hp Tetramer Protein in Plasma
In order to decipher these contradictory results, Hp PTM was 
checked. Native protein was purified using IP from OA and 
HC plasma (pooled from 12 patients in each group of TKR, 
UKR, and HCs), followed by protein separation with SDS- 
PAGE and native gels. The gels were then glycostained or 
phosphostained to detect any change in PTM of Hp tetra-
meric structure. Glycostaining analysis of Western blot 
membranes showed (Figure 4A) reductions in glycosylated 
Hp tetramers to 0.69-fold and 0.83-fold, respectively, in TKR 
and UKR plasma samples compared to HCs (Figure 4B), 
suggesting that the decreased levels of glycosylated Hp tetra-
mer in OA plasma may have contributed to the discrepancy 
between Western blot and ELISA data. However, phosphos-
taining of native gels showed no significant difference in 
band intensities of TKR, UKR, or HCs, indicating that 
there was no change in the phosphorylation status of Hp 
(Supplementary Figure 4). To further strengthen our data, 
the presence of autoantibodies in OA plasma was checked.
Presence of Autoantibodies Against Hp in 
Plasma
Although OA has not been considered an autoimmune 
disease,36 many autoantibodies have been reported in OA 
against such proteins as MAT2β-AAb,37 CHST14,38 and 
extracellular matrix proteins,39 but there have been no 
reports of the presence of autoantibodies against Hp. 
Interestingly, we identified Hp autoantibodies in OA sam-
ples. A band at 52 kDa was observed, suggesting recogni-
tion of Hpβ (Figure 4C). Densitometry analysis suggested 
1.57- and 1.31-fold increase in expression of autoantibo-
dies against Hpβ in TKR and UKR patients, respectively, 
compared to HCs (Figure 4D).
Table 1 (Continued). 














34 21.5 sp|P00915| 
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Carbonic anhydrase 
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Lower Levels of Hpβ and Its 
Ubiquitination in Disease
The ubiquitination status of of Hpβ was checked to find 
the reason for the presence of autoantibodies against Hp. 
Densitometry analysis of Western blots of ubiquitinated 
Hp from TKR/UKR and HCs was performed (Figure 5A). 
The results showed 0.22-fold and 0.37-fold lower ubiqui-
tination in TKR and UKR samples, respectively, compared 
to HCs (Figure 5B). We further checked Hpβ expression in 
disease using IP-eluted samples. SDS-PAGE of these fol-
lowed by silver staining (Figure 5C) suggested that there 
was significantly less Hpβ in TKR (0.47-fold) and UKR 
(0.41-fold) patients than HCs (Figure 5D). We further 
evaluated changes in ubiquitination of Hpβ, and found 
only 45% and 86% ubiquitination in TKR and UKR 
patients, respectively, compared to 96% ubiquitination of 
Hpβ in HCs. The change in ubiquitination levels among 
TKR/UKR patients compared to HCs suggests that ubiqui-
tination may possibly be PTMs involved in the production 
of autoantibodies against Hp in OA patients.
Confirmation of Increased Levels of Free 
Hemoglobin in OA Patients
Evaluation of free-hemoglobin levels in plasma was per-
formed using ELISAs. Average levels of free hemoglobin 
in TKR (n=45) and UKR (n=13) patients were 
Figure 1 Two-dimensional gel electrophoresis (2DE) of plasma proteins. Representative 2DE gel images of plasma proteins showing differentially expressed protein spots in 
TKR (gel 1), UKR (gel 2), and HCs (gel 3), marked with arrows and numbered 1–15. Protein spots were excised from the protein gel and identified by liquid chromatography 
with tandem mass spectrometry. 
Abbreviations: Mw, molecular weight; TKR, total knee replacement; UKR, unicompartmental knee replacement; HCs, healthy controls.
Figure 2 Venn diagrams of distribution of differentially expressed proteinsidentified in TKR and UKR. (A) Upregulated DEPs and their distribution among TKR and UKR: 30 
proteins were upregulated in TKR and 23 in UKR patients, while 21 were common to both TKR and UKR patients. (B) Similarly, 13 proteins in TKR and 20 proteins in UKR 
patients were downregulated and ten common to both TKR and UKR patients compared to healthy controls. 
Abbreviations: TKR, total knee replacement; UKR, unicompartmental knee replacement.
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significantly increased to 71 μg/ml and 66 μg/mL, respec-
tively, compared to 50 μg/mL (basal level in human 
plasma sample) in HC samples (n=40, P=0.003; Figure 
6A). Specificity (95%) and sensitivity (95%) evaluated by 
a receiver- operating characteristic (ROC) curve (Figure 
6B) confirmed true-positive results against false-positive 
ones.
Discussion
The current study was designed to identify novel OA- 
associated protein markers in severely affected OA patients 
(TKR and UKR cases, KL4 grade). The inconclusive clinical 
difference in deciding the type of joint replacement needed 
(TKR/UKR) for patients led us to perform a differential 
protein–profile study, with a belief that DEPs among TKR 
and UKR patients and HCs may additionally develop into 
biomarkers for surgeon’ choices.40 Using a proteomic 
approach, Hp was observed to have a better peptide score 
(209, Table 1), and was hence chosen for detailed study. The 
Hp protein is well known for its free hemoglobin–clearance 
activity, linked with the “complement and coagulation 
pathway”41 on DAVID pathway analysis. Free hemoglobin 
has been found to be associated with inflammation,42–44 and 
triggers complement activation via intravascular 
hemolysis.45 Hp consists of 2 α and 2 β chains: Hpα typically 
has 14–18 kDa molecular mass, while the molecular mass of 
Hpβ is 45 kDa.46 The HP gene harbors three types of Hp 
(1-1, 2-1, and 2-2).47 Hp1 and Hp2 are susceptible to various 
diseases (eg, cancer, cardiovascular disease, diabetes, rheu-
matoid arthritis),44,48 but their role in OA is not known. 
Although some reports have shown that Hp is upregulated 
in human OA serum samples49,50 and in synovial fluid of 
knee OA, further validation has not been carried out.51 We 
found significantly upregulated expression of Hpα in OA 
Figure 3 Validation of haptoglobin (Hp) expression in plasma. (A) Representative Western blot image of pooled plasma samples (TKR = 12, UKR = 12, HCs = 12) 
developed using anti-Hp antibody to detect Hpα. Hpα protein expression was normalized with total protein (lower panel) with Ponceau staining of membrane. (B) 
Densitometric analysis showing 1.5 fold upregulated Hpα in TKR (pP=0.0021) and 1.4-fold in UKR (pP=0.005) compared to HCs. Analysis was done using mean values of 
three independent experiments. (C) ELISA results showing Hp concentrations in blood plasma of TKR (n=40), UKR (n=11) and HCs (n=17). Average Hp concentration was 
found lowered by 1,417 ng/μL in TKR and 1,584 ng/μL compared to 1,655 ng/μL in HC plasma samples. The average fold change was found to be 0.8 (P=0.0003) and 0.95 
(P=0.05) in TKR and UKR compared to HCs, respectively. TKR also showed 0.89-fold (P=0.05) lower levels of Hp than UKR. 
Abbreviations: TKR, total knee replacement; UKR, unicompartmental knee replacement; HCs, healthy controls.
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cases (TKR and UKR) compared to HCs (Figure 3A and B), 
but this result was not replicated on ELISA. Three Hp pro-
teins have been identified but a reason for their up- or down-
regulation has not been put forward.48,49 These seemingly 
contradictory results supported our findings, and we reasoned 
that this may be possible if there is a difference in native 
tetramer form and its denatured form due to the possibility of 
degradation of protein monomers.46 Decreased levels of 
glycosylated Hp tetramer by native gel in OA plasma 
(Figure 4A) indicated that there was possibly degradation 
of proteins (Hp) and that may have triggered autoantibody 
production.52,53 Similar results were also noted while using 
Figure 4 Native-gel analysis and autoantibody detection against haptoglobin (Hp). (A) Representative glycoprotein-stained image of Western blot after running native PAGE 
using purified native Hp protein (tetramer) by immunoprecipitation from plasma samples indicated low levels of Hp tetramer (120 kDa) in TKR and UKR compared to HCs. 
(B) Densitometric analysis of glycosylated Hp native band shows lower levels of Hp tetramer in TKR (0.69-fold) and UKR (0.83-fold) than HCs. (C) Western blot was 
carried out after running SDS-PAGE using IP-eluted purified Hp protein and using blood plasma as source of primary antibodies followed by incubation with antihuman 
secondary antibody. The image represents increased levels of autoantibodies against Hpβ in TKR and UKR plasma compared to HCs. (D) Densitometric analysis of Western 
blot indicating subsequent increased level of autoantibodies (1.57-fold in TKR and 1.31-fold in UKR) against Hpβ compared to HC plasma samples. 
Abbreviations: Mw, molecular weight; TKR, total knee replacement; UKR, unicompartmental knee replacement; HCs, healthy controls; Hp, haptoglobin.
Figure 5 Ubiquitination of haptoglobin (Hp) by Western blot analysis. (A) Representative Western blot image showing that there were decreased levels of ubiquitinated 
Hpβ in TKR/UKR compared to HCs. Ubiquitination of Hpβ was detected using antiubiquitin antibody after immunoprecipitated Hp had been separated on SDS-PAGE 
followed by Western blot. (B) Densitometry analysis showing decreased ubiquitination of Hp in TKR (0.22-fold) and UKR (0.37-fold) compared to HCs. (C) Silver-stained 
image of gel after running SDS-PAGE using purified Hp, indicating lower levels of Hpβ in TKR and UKR patients than HCs. (D) Densitometry analysis of gel image for Hpβ 
showing lower levels of Hpβ in TKR (0.47-fold) and UKR (0.41-fold) than HCs. (E) Ubiquitination percentages of Hpβ in TKR, UKR, and HCs, showing 45.85% Hpβ) 
ubiquitinated in TKR and 86.48% in UKR compared to 96.92% in HCs. 
Abbreviations: TKR, total knee replacement; UKR, unicompartmental knee replacement; HCs, healthy controls; Ub, ubiquitination.
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individual plasma samples from OA patients (Supplementary 
Figure 5). However, the inaccurate protein folding in old age 
may also be an added reason for reduction in glycosylated 
active Hp.54 To confirm our hypothesis, autoantibodies 
against Hpβ subunit were identified and found to be 
increased in TKR and UKR (Figure 4, panel C). The invol-
vement of other PTMs (phosphorylation, ubiquitination) sta-
tus of Hp tetramer was also checked. Phosphorylation status 
revealed no change in Hp phosphorylation, indicating that 
autoantibody production was not due to phosphorylation 
(Supplementary Figure 4).
In ubiquitination, the E3 ubiquitin ligase 
depletes MARCH2 by targeting substrate-protein degrada-
tion, which may be responsible for reduced secretion of 
Hp.54,55 Highly decreased levels (Figure 5B) of ubiquiti-
nation in OA cases (TKR 45% and UKR 86%) compared 
to HCs (97%;Figure 5E) revealed decreased levels of E3 
ubiquitin ligase and altered degradation pathway for Hp.56 
Deregulated ubiquitination events are associated with 
immunological disorders and autoimmune and inflamma-
tory diseases,57 indicating that ubiquitination may be 
responsible for triggering autoantibody formation in OA. 
For more confirmation, protein subunits were separated 
and detected with SDS-PAGE58 using purified patient pro-
tein (Hp), revealing lower Hpβ levels at 45 kDa (Figure 
5C and D) and upregulation in Hpα (Supplementary 
Figure 6) in UKR/TKR patients compared to HCs. The 
autoantibody against the Hpβ may lead to its degradation, 
and hence lower levels of Hpβ may be responsible for 
lowering of Hp tetramer formation. However, the key 
factor responsible for autoantibody formation leading to 
the degradation of Hpβ remains unclear.
It has reported that the Hp precursor is an N-linked 
glycoprotein52 cleaved into α and β chains,46 and it is also 
known that active Hp binds with hemoglobin at specific 
sites on Hpβ and β-globin chain of hemoglobin59 and 
alters Hp’s biochemical profile,43 and thus the level of 
Hp increases for the clearance of circulating free hemo-
globin in blood,23 playing a role in the maintenance of 
cellular iron homeostasis. The increase in free-hemoglobin 
levels in UKR and TKR patients in our study suggested 
that Hp has strong potential to neutralize the adverse 
physiological effects of free Hb.41
Some reports have concluded that obesity is a low-grade 
systemic inflammation condition60 positively correlated with 
body-mass index (BMI), progressivelyincreasing the risk of 
knee OA.61,62 As per our observations (supplementary 
Table 1) the difference in BMI between the OA groups was 
not found to be significant (TKR and UKR). This may have 
been due to the small sample of UKR patients. Obese mice 
deficient in TNFα or TNFα receptors do not exhibit the 
typical increase in Hp mRNA.63 This signifies that upregula-
tion of Hp is specifically associated with inflammation,64 
neither due to the obesity nor increased BMI of OA patients. 
However, future studies looking at a larger cohort may be 
helpful to understand the chain of events more precisely. 
Figure 6 Free hemoglobin plasma–level analysis. (A) Circulating free hemoglobin in plasma was quantified in TKR (n=39), UKR (n=13), and HCs (n=13) using ELISA. The dot 
plot shows increased circulating free hemoglobin in TKR and UKR blood plasma compared to HCs. Free hemoglobin in TKR was found 71 μg/mL and 66 μg/mL in UKR 
compared to 50 μg/mL basal level in HCs. (B) ROC plot indicating individual protein abundance in each group with area under curve (AUC) of 0.8402 with 95% sensitivity 
and 95% specificity between the groups. 
Abbreviations: TKR, total knee replacement; UKR, unicompartmental knee replacement; HCs, healthy controls; ROC, receiver-operating characteristic; NS not significant.
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Inappropriate functioning of Hp leads to wear and tear of the 
joints.65,66 Our study provides new evidence that lower 
levels of Hp tetramer may be one of the factors associated 
with initiation of inflammation in OA.
Conclusion
Hp was found to be an important factor in regulating 
hemoglobin homeostasis and inflammation in severely 
affected knee-OA patients (TKR and UKR surgical 
cases). Downregulation of active Hp tetramer accompa-
nied by increased levels of free hemoglobin indicated poor 
clearance of free hemoglobin in patients with severe OA, 
and may be responsible for disease severity. This study 
thus contributes to understanding of the inflammation cas-
cade in severe OA patients, and should be helpful in 
understanding its etiology and developing new treatment 
strategies.
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